American Society of Hirudotherapy

Complement resistance is essential for colonization of the digestive tract of Hirudo medicinalis by Aeromonas strains

Basic science / microbiology published in Appl Environ Microbiol (2003)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Safety & Infection ControlGenomics & ProteomicsBraschler TR et al. · Applied and environmental microbiology, 2003

Abstract

From the crop of the medicinal leech, Hirudo medicinalis, only Aeromonas veronii bv. sobria can be cultured consistently. Serum-sensitive A. veronii mutants were unable to colonize H. medicinalis, indicating the importance of the mammalian complement system for this unusual simplicity. Complementation of one selected mutant restored its ability to colonize. Serum-sensitive mutants are the first mutant class with a colonization defect for this symbiosis.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAeromonasAnimalsComplement System ProteinsCulture MediaDigestive SystemDrug Resistance, BacterialLeechesSymbiosis

Summary

Demonstrates that complement resistance is required for Aeromonas veronii bv. sobria colonization of the medicinal leech digestive tract. Serum-sensitive mutants failed to colonize but complementation restored colonization.

Why This Matters for Hirudotherapy

This study (Braschler et al., Applied and Environmental Microbiology 2003) found that only Aeromonas veronii bv. sobria can be consistently cultured from the crop of the medicinal leech Hirudo medicinalis, and that serum-sensitive A. veronii mutants failed to colonize the leech while complementation of a selected mutant restored colonization, identifying resistance to the (mammalian, blood-meal-derived) complement system as essential for this symbiosis and describing serum-sensitive mutants as the first colonization-defective class for this partnership. This is directly relevant to hirudotherapy because Aeromonas is the leech-associated bacterium most implicated in post-leeching wound infections, so understanding why it uniquely colonizes the leech gut informs infection risk and antibiotic-prophylaxis rationale. Honest caveat: this is preclinical microbiology using bacterial mutants and the leech host to dissect a symbiotic mechanism; it does not study human infection rates or any clinical leech-therapy outcome.

Citation

Complement resistance is essential for colonization of the digestive tract of Hirudo medicinalis by Aeromonas strains.

Braschler TR et al. · Applied and environmental microbiology, 2003

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.